EverFortune.AI Co., Ltd.

Ever Fortune.AI develops groundbreaking technology to enhance medical workflow and boost patient outcomes in a range of specialties, with a focus in oncology, neurology, cardiovascular and other diseases, as well as the use of digital medicine, and precision medicine. Our vision is to go beyond medicine, and bring solutions to experts anytime, anywhere.

EVERTECH

planning

EXCELsior Pharmatech

Excelsior group has been dedicated to specialty medicines and medical examinations in rare diseases for more than 2 decades. In 2016, Excelsior group established a TGF-beta research center and start up new drug development projects to screen new drug candidates of enhancers and inhibitors targeting at TGF-beta activities in various diseases, such as wound healing, cardiovascular diseases, autoimmune diseases, liver cirrhosis, pulmonary fibrosis, neurodegenerative diseases, and cancer treatments. In 2020, Excelsior group is expanding our team in the field of rare diseases and establish a new research center of specific diseases aim at genetic and metabolic disorders in National Biotechnology Research Park, NBRP. In NBRP, we are investing in precision medical testing, epidemiology study, new drug development, and novel therapeutic technologies in various rare diseases. Besides, we are also looking for more strategic alliances with Academia Sinica, National Health Research Institute and leading medical centers in Taiwan. Our aim is to establish a world-class laboratories in the research of TGF-beta and specific diseases and extend our services to Asian populations.

Exland Biotechnology Inc.

Exland Biotechnology Inc. from Taiwan is the manufacturer, suppliers, and exporter of functional plant extracts. Our R&D department is staffed with the professional and experienced experts in plants and traditional herbs. We are committed to produce plant extracts and traditional herbs extracts in more than 10 years.

With patented Super Dash® high efficiency extraction technologies Exland Biotechnology Inc. is able to purify active ingredients in a short period of time. By utilizing pure water extraction, our products have ZERO organic solvent residues. It’s better and healthier for the body.

We cooperate with the leading food companies worldwide, manufactured more than 100 high quality plant extracts and serve as a professional OEM/ODM extraction company in Taiwan.

ExoOne Bio Co., Ltd.

(Booth location: I 424/1F)Exosomes are regarded the rising star in recent bio-medical industry. Due to its advantages in safety and commercial values comparing to cell therapy, exosomes are broadly applied for diseases treatment, diagnosis, & anti-aging purpose.
ExoOne Bio Co. was established by Dr. Tzou-Yien Lin, the former Minister of Health in Taiwan, in 2020. ExoOne Bio is a pioneered company in Taiwan focusing exosome development for degenerative diseases treatment and for anti-aging application. The company has built the standardized procedures of MSCs culturing, exosome purification process, exosome analysis platform, & functional test models. Our results in exosome purity and productivity in terms of particle number exceed the data published by international company, which demonstrates the company's core strength has achieved international standard.
In this event, we plan to share our achievements in exosomes' development and look forward to work with potential partners for in-depth development plans and for business collaboration.

FanRuan Software Co., Ltd.

#FineReport
FanRuan Software Co., Ltd. (hereinafter referred to as FanRuan), founded in 2006, is a professional big data BI and analytics platform vendor in China. Specializing in BI and data analysis, we are committed to providing one-stop BI solutions to businesses around the globe.
We are the front runner in terms of professional standards, organizational size, service scope and clients, and have been highly recognized by many professional consulting organizations including Gartner, IDC and CCID. We were selected as one of “Forbes Top 50 Potential Chinese Unlisted Companies” in 2018 and one of “Top 50 Chinese Big Data Enterprises" for three consecutive years in 2018, 2019 and 2020.

Far Eas Tone Telecommunications Co., Ltd.

Using world-class 5G and new technologies, FET builds a "5G telemedicine platform" to provide mobile, zero-day telemedicine services.In this year, 5G telemedicine services spread across 12 counties and 33 districts. During the Covid-19 period, we have also assisted many hospitals to remote clinical services and smoothly carry out routine medical treatment.

FAR EAST BIO-TEC CO., LTD

Far East Biotech Co., Ltd. (FEBICO) is a professional microalgae biotechnology company with decades of professional experience in product development.

1.Private labeling for dietary Supplements
*ISO 22000 and HACCP-certified
*Chlorella/Spirulina supplied to more than 60 countries around the world for more than 40 years.
*Apogen® : An extract derived from an unique microalgae strain FEM-101, which contains active ingredients including allophycocyanin (APC), C-phycocyanin (CPC), spirulina growth factor, sulfated polysaccharides, peptides, nucleic acids, amino acids and trace elements.
2. Biomedical material:
FLOGEN®: Phycobiliproteins such as phycoerythrin and phycocyanin have been supplied to major flow reagent manufacturers all over the world.
3. New drug development:
Hepatitis B, cirrhosis and acute hepatitis, herpes virus
herpes virus
4. Regenerative Medicine:
Development of a cost-effective, high-performance, versatile and non-adaptable cell supplement across different cell types.

Fashion Intelligence Co., Ltd.

test

Fecula Biotech Co., Ltd.

Fecula Biotech Co., Ltd. is a microbiome research company located in southern Taiwan. Our missions include (1) to develop novel microbiome-based therapeutics aimed at the prevention and treatment of gastrointestinal cancers. The development of our screening platforms helps to identify key gut microbiota and identify its metabolites to further match each treatment scheme for chemotherapy or immunotherapy. Our work on microbiota-related adjuvant/neo-adjuvant therapy is still in its preclinical phase; (2) to implement an evidence-based approach in our development of microbiome-based dietary supplements. The function of these supplements varies from improving glucose metabolism, which increases day-to-day energy, to boosting calcium that strengthens bones. Fecula Biotech uses Taiwan domestic agricultural and fishery by-products in an attempt to apply pioneering research that transfers agricultural recycling into biological nutritional benefits. The microbiota-related (probiotic) dietary supplements were launched earlier this year and market products all over the world. Creative innovation has allowed the company to grow our influence within the biotechnology industry alongside the increased global attention paid to the health implications of the gut microbiome.